L'Hôtel-Dieu de Québec
Hôtel-Dieu de Québec
11 Côte du Palais
Québec, QC
Canada G1R 2J6

Dernières nouvelles

Information non disponible

44 enregistrements « 1 de 5 »

Brown JC, Ma C, Shi Q, Niedzwiecki D, Zemla T, Couture F, Kuebler P, Kumar P, Hopkins JO, Tan B, Krishnamurthi S, O'Reilly EM, Shields AF, Meyerhardt JA

Association between physical activity and the time course of cancer recurrence in stage III colon cancer

Article de revue

Br J Sports Med, 2023.

Résumé | Liens:

Cheng E, Shi Q, Shields AF, Nixon AB, Shergill AP, Ma C, Guthrie KA, Couture F, Kuebler P, Kumar P, Tan B, Krishnamurthi SS, Ng K, O'Reilly EM, Brown JC, Philip PA, Caan BJ, Cespedes Feliciano EM, Meyerhardt JA

Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer

Article de revue

JAMA Oncol, 9 (3), 2023.

Résumé | Liens:

Benoit A, B Boies MH, Déry N, M Garcia L, Simard M, Poirier M, Delage R, Lortal Canguilhem B, Doyle C, Larouche JF, Couture F, Lemieux C

CAR T-Cells for the Treatment of Refractory or Relapsed Large B-Cell Lymphoma: A Single-Center Retrospective Canadian Study

Article de revue

Clin Lymphoma Myeloma Leuk, 23 (3), 2023.

Résumé | Liens:

Lee S, Ma C, Shi Q, Kumar P, Couture F, Kuebler P, Krishnamurthi S, Lewis D, Tan B, Goldberg RM, Venook A, Blanke C, O'Reilly EM, Shields AF, Meyerhardt JA

Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702

Article de revue

J Clin Oncol, 41 (5), 2023.

Résumé | Liens:

Lacombe L, Hovington H, Brisson H, Mehdi S, Beillevaire D, Émond JP, Wagner A, Villeneuve L, Simonyan D, Ouellet V, Barrès V, Latour M, Aprikian A, Bergeron A, Castonguay V, Couture F, Chevalier S, Brimo F, Fazli L, Fleshner N, Gleave M, Karakiewicz PI, Lattouf JB, Trudel D, van der Kwast T, Mes-Masson AM, Pouliot F, Fradet Y, Audet-Walsh E, Saad F, Guillemette C, Lévesque E

UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways

Article de revue

Cancer Lett, 553 , 2023.

Résumé | Liens:

Brown JC, Ma C, Shi Q, Fuchs CS, Meyer J, Niedzwiecki D, Zemla T, Couture F, Kuebler P, Kumar P, Lewis D, Tan B, Krishnamurthi S, O'Reilly EM, Shields AF, Meyerhardt JA

Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)

Article de revue

J Clin Oncol, 41 (2), 2023.

Résumé | Liens:

Renouf DJ, Loree JM, Knox JJ, Topham JT, Kavan P, Jonker D, Welch S, Couture F, Lemay F, Tehfe M, Harb M, Aucoin N, Ko YJ, Tang PA, Ramjeesingh R, Meyers BM, Kim CA, Du P, Jia S, Schaeffer DF, Gill S, Tu D, O'Callaghan CJ

The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma

Article de revue

Nat Commun, 13 (1), 2022.

Résumé | Liens:

Roy V, Ruel S, Ivers H, Savard MH, Gouin JP, Caplette-Gingras A, Lemieux J, Couture F, Savard J

Stress-buffering effect of social support on immunity and infectious risk during chemotherapy for breast cancer

Article de revue

Brain Behav Immun Health, 10 , 2021.

Résumé | Liens:

Long GV, Robert C, Butler MO, Couture F, Carlino MS, O'Day S, Atkinson V, Cebon JS, Brown MP, Dalle S, Hill AG, Gibney GT, McCune S, Menzies AM, Niu C, Ibrahim N, Moreno BH, Diab A

Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules

Article de revue

Clin Cancer Res, 27 (19), 2021.

Résumé | Liens:

Gambaro K, Marques M, McNamara S, Couetoux du Tertre M, Diaz Z, Hoffert C, Srivastava A, Hébert S, Samson B, Lespérance B, Ko YJ, Dalfen R, St-Hilaire E, Sideris L, Couture F, Burkes R, Harb M, Camlioglu E, Gologan A, Pelsser V, Constantin A, Greenwood CMT, Tejpar S, Kavan P, Kleinman CL, Batist G

Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer

Article de revue

Clin Transl Med, 11 (4), 2021.

Résumé | Liens:

44 enregistrements « 1 de 5 »
Signaler des ajouts ou des modifications

Projets terminés récemment

  • Multi-pathway cholesterol depletion on top of FOLFIRINOX in newly diagnosed metastatic pancreatic adenocarcinoma: a feasibility and proof-of-concept study, du 2019-10-01 au 2021-09-30
Information provenant du registre des projets de recherche de l'Université Laval